Active ingredient
Erythromycin
107 finished FDA listings contain Erythromycin as their only active ingredient; 1 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- ERYTHROMYCIN, ERYTHROMYCIN ESTOLATE, ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN LACTOBIONATE, ERYTHROMYCIN PHOSPHATE, ERYTHROMYCIN STEARATE
- Dosage forms
- Capsule, Delayed Release, Capsule, Delayed Release Pellets, For Suspension, Gel, Granule, For Suspension, Injection, Powder, For Solution, Injection, Powder, Lyophilized, For Solution, Ointment, Solution, Suspension, Swab, Tablet, Tablet, Coated, Tablet, Delayed Release, Tablet, Film Coated
- Routes
- Intravenous, Ophthalmic, Oral, Topical
- Manufacturers / labelers
- 43
- Strengths listed
- 20 mg/g · 20 mg/ml · 200 mg/5ml · 250 mg/1 · 333 mg/1 · 400 mg/1 · 400 mg/5ml · 5 mg/g · 500 mg/1 · 500 mg/10ml
- Brand names in FDA listings
- E.e.s, E.e.s 400, Ery, Ery-Ped, Ery-Tab, Erythrocin Lactobionate, Erythromycin Ethylsuccinate
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 4053
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 050207 | CARNEGIE | 1965-04-02 | 8 |
| ANDA 061621 | CARNEGIE | 1972-07-11 | 5 |
| ANDA 061904 | CARNEGIE | 1975-03-03 | 1 |
| ANDA 062055 | ANI PHARMS | 1978-11-27 | 3 |
| NDA 050536 | DR REDDYS LABS SA | 1981-01-26 | 1 |
| ANDA 062298 | PHARMOBEDIENT | 1982-03-29 | 6 |
| ANDA 061905 | PHARMOBEDIENT | 1982-08-12 | 2 |
| ANDA 062447 | PADAGIS US | 1983-09-26 | 3 |
| NDA 050609 | HOSPIRA | 1986-09-24 | 1 |
| ANDA 062746 | PHARMOBEDIENT | 1986-12-22 | 1 |
| ANDA 062687 | MICRO LABS | 1988-02-05 | 1 |
| ANDA 063038 | PADAGIS US | 1991-01-11 | 3 |
| ANDA 063211 | PADAGIS US | 1993-01-29 | 4 |
| ANDA 064067 | BAUSCH AND LOMB INC | 1994-07-29 | 11 |
| ANDA 064126 | PADAGIS US | 1996-07-03 | 3 |
| ANDA 064030 | SENTISS | 1996-07-18 | 7 |
| ANDA 210954 | AMNEAL PHARMS CO | 2019-07-02 | 3 |
| ANDA 211204 | AMNEAL PHARMS | 2019-11-01 | 4 |
| ANDA 212015 | TORRENT | 2020-07-06 | 4 |
| ANDA 214549 | TEVA PHARMS USA INC | 2021-02-11 | 3 |
| ANDA 213628 | CADILA PHARMS LTD | 2021-06-28 | 6 |
| ANDA 211975 | TORRENT | 2021-07-26 | 5 |
| ANDA 216066 | ALKEM LABS LTD | 2022-07-13 | 2 |
| ANDA 216212 | CADILA PHARMS LTD | 2022-11-21 | 8 |
| ANDA 212693 | ZYDUS LIFESCIENCES | 2023-03-07 | 4 |
| ANDA 215661 | ALEMBIC | 2023-08-24 | 4 |
| ANDA 216761 | GLAND | 2024-11-19 | 3 |
Official labeling on DailyMed
- ERYTHROMYCIN OINTMENT [BAUSCH & LOMB INCORPORATED] · version 12 · 2026-09-02
- ERYTHROMYCIN LACTOBIONATE INJECTION, POWDER, FOR SOLUTION [PIRAMAL CRITICAL CARE INC.] · version 4 · 2026-08-18
- ERY (ERYTHROMYCIN) SWAB [PADAGIS ISRAEL PHARMACEUTICALS LTD] · version 10 · 2026-07-30
- ERYTHROMYCIN OINTMENT [SPORTPHARM LLC] · version 1 · 2026-07-24
- ERYTHROMYCIN LACTOBIONATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ARMAS PHARMACEUTICALS INC.] · version 1 · 2026-07-13
- E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET [REMEDYREPACK INC.] · version 2 · 2026-06-24
- ERYTHROMYCIN ETHYLSUCCINATE FOR SUSPENSION [BRYANT RANCH PREPACK] · version 1 · 2026-06-08
- ERYTHROMYCIN ETHYLSUCCINATE FOR SUSPENSION [BRYANT RANCH PREPACK] · version 1 · 2026-06-08
- ERYTHROMYCIN ETHYLSUCCINATE FOR SUSPENSION [KANCHAN HEALTHCARE INC] · version 7 · 2026-05-21
- ERYTHROMYCIN TABLET, COATED [GOLDEN STATE MEDICAL SUPPLY, INC.] · version 3 · 2026-05-06
- ERYTHROMYCIN OINTMENT [CARDINAL HEALTH 107, LLC] · version 9 · 2026-05-06
- ERYTHROMYCIN OINTMENT [NUCARE PHARMACEUTICALS,INC.] · version 1 · 2026-05-04
Showing the 12 most recent of 73 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.